Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines

PLoS Neglected Tropical Diseases

Volumn 8, Issue 7, 2014, Pages

  van Griensven, Johan ^a   Ritmeijer, Koert ^b   Lynen, Lutgarde ^a   Diro, Ermias ^a,c  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c UNIVERSITY OF GONDAR   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DISEASE RE-EMERGENCE; DISEASE TRANSMISSION; HEALTH CARE PLANNING; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOCOMPETENCE; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS; WORLD HEALTH ORGANIZATION;

EID: 84904981948     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002916     Document Type: Article

References (15)

1. Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334-359.
2. Desjeux P, Alvar J, (2003) Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 97 (Suppl 1):: 3-15.
3. Lopez-Velez R, Casado JL, Pintado V, (2001) Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART). Clin Microbiol Infect 7: 394-395.
4. Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, et al. (2011) Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. Clin Infect Dis 53: e152-158.
5. Hurissa Z, Gebre-Silassie S, Hailu W, Tefera T, Lalloo DG, et al. (2010) Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Trop Med Int Health 15: 848-855.
6. ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN, (2008) Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis 46: 1702-1709.
7. WHO (1995) Report on the consultative meeting on VL/HIV coinfection. Geneva, Switzerland: World Health Organization.
8. WHO (2010) Control of the leishmaniasis. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010. WHO technical report series 949. Geneva, Switzerland: World Health Organization.
9. WHO (1990) Acquired immunodeficiency syndrome (AIDS). Interim proposalfor a WHO staging system for HIV infection and disease. Geneva, Switzerland: World Health Organization.
10. WHO (2007) WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: World Health Organization.
11. WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach, 2010 Revision. Geneva, Switzerland: Word Health Organization.
12. WHO (2006) Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach, 2006 Revision. Geneva, Switzerland: Word Health Organization.
13. WHO (2003) Scaling up antiretroviral therapy in resource limited settings: treatment guidelines for a public health approach; 2003 revision. Geneva, Switzerland: World Health Organization.
14. WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: World Health Organization.
15. WHO (2012) WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva, Switzerland: World Health Organization.